Showing results (21-30 of 38) with videos related to
Sort By:
Pageof 4
Biology|June 24, 2022
Can Telemedicine Optimize the HCV Care Cascade in People Who Use Drugs? Features of an Innovative Decentralization Model and Comparison with Other Micro-Elimination StrategiesRiccardo Nevola, Valerio Rosato, Vincenza Conturso, et al.Life (Basel, Switzerland)|January 5, 2021
Directly Acting Antiviral-Based Treatment for HCV-Infected Persons Who Inject Drugs: A Multicenter Real-Life StudyVincenzo Messina, Lorenzo Onorato, Giovanni Di Caprio, et al.Pathogens (Basel, Switzerland)|November 27, 2025
Epidemiologic Characteristics Determining the Choice of Direct-Acting Antiviral Therapy in HCV Patients: An Italian Real-World Evidence StudyNicola Pugliese, Fabio Conti, Valerio Rosato, et al.Infection|January 17, 2018
Influence of antiviral therapy on the liver stiffness in chronic HBV hepatitisLuca Rinaldi, Antonio Ascione, Vincenzo Messina, et al.World Journal of Gastroenterology|March 16, 2017
Clinical features and natural history of cryptogenic cirrhosis compared to hepatitis C virus-related cirrhosisLuca Rinaldi, Fabio Nascimbeni, Mauro Giordano, et al.Biology|April 23, 2022
Epidemiology of HCV and HBV in a High Endemic Area of Southern Italy: Opportunities from the COVID-19 Pandemic-Standardized National Screening or One Tailored to Local Epidemiology?Riccardo Nevola, Vincenzo Messina, Aldo Marrone, et al.Reviews on Recent Clinical Trials|December 18, 2015
Impact of Telaprevir in HCV Patients with Cirrhosis and RVR: Real-Life Data from Boceprevir or Telaprevir based "Triple Therapy" Experience in Southern ItalyFilomena Morisco, Mario Masarone, Valerio Rosato, et al.International Journal of Molecular Sciences|April 28, 2023
HBV Infection and Host Interactions: The Role in Viral Persistence and OncogenesisRiccardo Nevola, Domenico Beccia, Valerio Rosato, et al.Biology|July 29, 2023
Gender Differences in the Pathogenesis and Risk Factors of Hepatocellular CarcinomaRiccardo Nevola, Giovanni Tortorella, Valerio Rosato, et al.Journal of Viral Hepatitis|September 28, 2021
Factors affecting long-term changes of liver stiffness in direct-acting anti-hepatitis C virus therapy: A multicentre prospective studyValerio Rosato, Antonio Ascione, Riccardo Nevola, et al.Pageof 4